TARGETED COVALENT REVERSIBLE BCR-ABL INHIBITORS
Ph.D
Saved in:
Main Author: | DAVID QUACH THANH TRUONG |
---|---|
Other Authors: | INTEGRATIVE SCIENCES & ENGINEERING PROG |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/182680 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia
by: Rauzan M., et al.
Published: (2020) -
C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion
by: Hayashi, Y., et al.
Published: (2016) -
Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors
by: Zhang, C., et al.
Published: (2014) -
Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor
by: Jin, F., et al.
Published: (2014) -
A positive role for c-Abl in Atm and Atr activation in DNA damage response
by: Wang, X., et al.
Published: (2014)